Hulu has released some of the first images of the sixth and final season of The Handmaid's Tale, which is slated to premiere ...
Data shows Latino and Black people make up nearly 30% of the Bay Area population but only about 10% of active medical ...
Democratic Party leaders and their donors bear responsibility for the increasingly widespread view of trans rights as ...
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
The first look photos - and a teaser from Disney - deliver the first tease at what the sixth and final season of the hit Hulu ...
On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $96.57 which represents a decrease of $-1.33 or -1.36% from the prior close of $97.9. The stock opened at $96.05 and ...
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
In June, the FDA removed a requirement for clinicians to report serious cases of the two most common side effects as part of ...
Despite a robust HIV portfolio and growing oncology sales, Gilead struggles to diversify revenue streams significantly. Learn ...
Watch out, Gilead and Novartis: there's a new CAR-T in town. Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl, a late entry to the heated CD19 CAR-T cell therapy ...
Aileen Lamb hopes the approval of a new cancer treatment drug will give patients 'hope', after she was given the all clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback